Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Prospect Capital Corporation (PSEC)

Page 1 of 2

Is Prospect Capital Corporation (NASDAQ:PSEC) a buy here? Hedge funds are in a bullish mood. The number of bullish hedge fund positions increased by 4 in recent months.

At the moment, there are a multitude of methods market participants can use to analyze their holdings. A couple of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite investment managers can trounce their index-focused peers by a superb amount (see just how much).

Prospect Capital Corporation (NASDAQ:PSEC)

Equally as beneficial, optimistic insider trading activity is another way to parse down the investments you’re interested in. Just as you’d expect, there are plenty of reasons for an insider to get rid of shares of his or her company, but only one, very clear reason why they would buy. Several empirical studies have demonstrated the market-beating potential of this strategy if shareholders understand what to do (learn more here).

Now, it’s important to take a look at the recent action surrounding Prospect Capital Corporation (NASDAQ:PSEC).

Hedge fund activity in Prospect Capital Corporation (NASDAQ:PSEC)

In preparation for this year, a total of 9 of the hedge funds we track were long in this stock, a change of 80% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were increasing their holdings significantly.

Of the funds we track, Ken Griffin’s Citadel Investment Group had the most valuable position in Prospect Capital Corporation (NASDAQ:PSEC), worth close to $33.7 million, comprising 0.1% of its total 13F portfolio. On Citadel Investment Group’s heels is Cliff Asness of AQR Capital Management, with a $8 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Some other peers that hold long positions include John Fichthorn’s Dialectic Capital Management, John Overdeck and David Siegel’s Two Sigma Advisors and Robert B. Gillam’s McKinley Capital Management.

Consequently, key hedge funds have jumped into Prospect Capital Corporation (NASDAQ:PSEC) headfirst. Dialectic Capital Management, managed by John Fichthorn, established the biggest position in Prospect Capital Corporation (NASDAQ:PSEC). Dialectic Capital Management had 1.8 million invested in the company at the end of the quarter. Michael Johnston’s Steelhead Partners also initiated a $0.6 million position during the quarter. The other funds with new positions in the stock are David Costen Haley’s HBK Investments, Steven Cohen’s SAC Capital Advisors, and Joel Greenblatt’s Gotham Asset Management.

What have insiders been doing with Prospect Capital Corporation (NASDAQ:PSEC)?

Bullish insider trading is most useful when the company in question has experienced transactions within the past half-year. Over the last six-month time period, Prospect Capital Corporation (NASDAQ:PSEC) has experienced 3 unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Prospect Capital Corporation (NASDAQ:PSEC). These stocks are Encore Capital Group, Inc. (NASDAQ:ECPG), Pacific Coast Oil Trust (NYSE:ROYT), Blackrock Kelso Capital Corp. (NASDAQ:BKCC), Triangle Capital Corporation (NYSE:TCAP), and The India Fund, Inc. (NYSE:IFN). All of these stocks are in the asset management industry and their market caps are closest to PSEC’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!